BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11535875)

  • 61. Nonsteroidal anti-inflammatory drugs and aspirin for the prevention of colorectal adenomas and cancer: a systematic review.
    Asano TK; McLeod RS
    Dis Colon Rectum; 2004 May; 47(5):665-73. PubMed ID: 15054679
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Aspirin, non-steroidal anti-inflammatory drugs and protection from colorectal cancer: a review of the epidemiological evidence.
    Weiss HA; Forman D
    Scand J Gastroenterol Suppl; 1996; 220():137-41. PubMed ID: 8898452
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The preventive effects of low-dose enteric-coated aspirin tablets on the development of colorectal tumours in Asian patients: a randomised trial.
    Ishikawa H; Mutoh M; Suzuki S; Tokudome S; Saida Y; Abe T; Okamura S; Tajika M; Joh T; Tanaka S; Kudo SE; Matsuda T; Iimuro M; Yukawa T; Takayama T; Sato Y; Lee K; Kitamura S; Mizuno M; Sano Y; Gondo N; Sugimoto K; Kusunoki M; Goto C; Matsuura N; Sakai T; Wakabayashi K
    Gut; 2014 Nov; 63(11):1755-9. PubMed ID: 24488498
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antagonistic effects of aspirin and folic acid on inflammation markers and subsequent risk of recurrent colorectal adenomas.
    Ho GY; Xue X; Cushman M; McKeown-Eyssen G; Sandler RS; Ahnen DJ; Barry EL; Saibil F; Bresalier RS; Rohan TE; Baron JA
    J Natl Cancer Inst; 2009 Dec; 101(23):1650-4. PubMed ID: 19822838
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Eicosapentaenoic acid and aspirin for colorectal adenomas.
    Danış N; Tekin F
    Turk J Gastroenterol; 2019 Feb; 30(2):213-214. PubMed ID: 30843862
    [No Abstract]   [Full Text] [Related]  

  • 66. Effect of Low-dose and Standard-dose Aspirin on PGE
    Drew DA; Schuck MM; Magicheva-Gupta MV; Stewart KO; Gilpin KK; Miller P; Parziale MP; Pond EN; Takacsi-Nagy O; Zerjav DC; Chin SM; Mackinnon Krems J; Meixell D; Joshi AD; Ma W; Colizzo FP; Carolan PJ; Nishioka NS; Staller K; Richter JM; Khalili H; Gala MK; Garber JJ; Chung DC; Yarze JC; Zukerberg L; Petrucci G; Rocca B; Patrono C; Milne GL; Wang M; Chan AT
    Cancer Prev Res (Phila); 2020 Oct; 13(10):877-888. PubMed ID: 32718943
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Design and baseline characteristics of participants in a phase III randomized trial of celecoxib and selenium for colorectal adenoma prevention.
    Thompson P; Roe DJ; Fales L; Buckmeier J; Wang F; Hamilton SR; Bhattacharyya A; Green S; Hsu CH; Chow HH; Ahnen DJ; Boland CR; Heigh RI; Fay DE; Martinez ME; Jacobs E; Ashbeck EL; Alberts DS; Lance P
    Cancer Prev Res (Phila); 2012 Dec; 5(12):1381-93. PubMed ID: 23060037
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.
    Chan AT; Giovannucci EL; Meyerhardt JA; Schernhammer ES; Curhan GC; Fuchs CS
    JAMA; 2005 Aug; 294(8):914-23. PubMed ID: 16118381
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
    Gill S; Sinicrope FA
    Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dietary fibre for the prevention of colorectal adenomas and carcinomas.
    Asano T; McLeod RS
    Cochrane Database Syst Rev; 2002; (2):CD003430. PubMed ID: 12076480
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Aspirin and nonaspirin nonsteroidal antiinflammatory drug use and occurrence of colorectal adenoma in Black American women.
    Barber LE; Bertrand KA; Sheehy S; White LF; Roy HK; Rosenberg L; Palmer JR; Petrick JL
    Int J Cancer; 2023 Dec; 153(12):1978-1987. PubMed ID: 37555819
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Distribution characteristics and risk factors of colorectal adenomas].
    Zhou H; Shen Z; Zhao J; Zhou Z; Xu Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jun; 21(6):678-684. PubMed ID: 29968244
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Plasma lipoxin A
    Fedirko V; McKeown-Eyssen G; Serhan CN; Barry EL; Sandler RS; Figueiredo JC; Ahnen DJ; Bresalier RS; Robertson DJ; Anderson CW; Baron JA
    Mol Carcinog; 2017 Aug; 56(8):1977-1983. PubMed ID: 28218420
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group.
    Schatzkin A; Lanza E; Corle D; Lance P; Iber F; Caan B; Shike M; Weissfeld J; Burt R; Cooper MR; Kikendall JW; Cahill J
    N Engl J Med; 2000 Apr; 342(16):1149-55. PubMed ID: 10770979
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme.
    Logan RF; Little J; Hawtin PG; Hardcastle JD
    BMJ; 1993 Jul; 307(6899):285-9. PubMed ID: 8374373
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on Outcome.
    Anderson JC; Baron JA; Ahnen DJ; Barry EL; Bostick RM; Burke CA; Bresalier RS; Church TR; Cole BF; Cruz-Correa M; Kim AS; Mott LA; Sandler RS; Robertson DJ
    Gastroenterology; 2017 Jun; 152(8):1933-1943.e5. PubMed ID: 28219690
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial.
    Barry EL; Sansbury LB; Grau MV; Ali IU; Tsang S; Munroe DJ; Ahnen DJ; Sandler RS; Saibil F; Gui J; Bresalier RS; McKeown-Eyssen GE; Burke C; Baron JA
    Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2726-33. PubMed ID: 19755647
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Efficacy of Aspirin in Preventing the Recurrence of Colorectal Adenoma: a Renewed Meta-Analysis of Randomized Trials.
    Zhao TY; Tu J; Wang Y; Cheng DW; Gao XK; Luo H; Yan BC; Xu XL; Zhang HL; Lu XJ; Wang YJ
    Asian Pac J Cancer Prev; 2016; 17(5):2711-7. PubMed ID: 27268656
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Aspirin, non-steroidal anti-inflammatory drugs and colorectal neoplasia: future challenges in chemoprevention.
    Chan AT
    Cancer Causes Control; 2003 Jun; 14(5):413-8. PubMed ID: 12946035
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Can We Select Patients for Colorectal Cancer Prevention with Aspirin?
    Kraus S; Sion D; Arber N
    Curr Pharm Des; 2015; 21(35):5127-34. PubMed ID: 26369678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.